by Elena Iemma | Apr 3, 2024 | Events
The 16th annual 2024 Westin Immunogenicity Seminar will be taking place on Thursday, October 17th. All events (including a networking cocktail hour, key takeaway panel, and networking cocktail hour) will be located at the Westin Tokyo Hotel in Meguro, Tokyo,...
by Elena Iemma | Dec 20, 2023 | Featured, News
PROVIDENCE, RI, December 20, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”), an internationally recognized leader in the field of immunogenicity, today announced that Eisai Co. Ltd. (“Eisai”) has licensed EpiVax’s ISPRI toolkit for immunogenicity risk assessment of...
by Corey Iacono | Mar 13, 2023 | Featured, Thinking Out Loud -Blog
Silicon Valley Eats its Own Accelerated by twitter alerts advising venture investors to pull their cash, the Silicon Valley Bank in Santa Clara collapsed and was taken over by the FDIC on Friday. Tech Brahmans on the “All In” Podcast (the podcast I love to...
by Elena Iemma | Mar 3, 2023 | Events
The EpiVax team had a great time in Tokyo hosting the 15th annual Westin Immunogenicity Seminar! Thank you to all who were in attendance. See pictures from the event below. Interested in attending the Westin Immunogenicity Seminar in 2024? Sign up here! The 15th...
by Annie De Groot | Oct 23, 2019 | Featured, News, Thinking Out Loud -Blog
Announced today, Chugai Pharmaceutical Co., Ltd. (“Chugai”), a member of the Roche Group, will extend the company’s licensed access to the Immunogenicity Screening and Protein Reengineering Interface (ISPRI) toolkit developed by EpiVax, Inc....
